And it would be mainly aimed at therapeutic alliance, connecting with them, building trust as much as possible
Clarity Around Medication Types and Limitations Minor issues Willow includes a statement that compounded drugs do not require FDA approval and are exempt from undergoing safety, effectiveness, or manufacturing reviews. Thats an important disclosure
Personalized GLP-1 Therapy and Genetic Factors in Cholesterol Response Not all patients respond identically to semaglutide, and genetic factors influence how effectively someone's cholesterol profile will improve
doi:10.1093/jn/130.7.1835S
Yes: the Phase 2 trial recorded diarrhea in about 33% of the 12 mg group, along with stomach cramps, upset stomach, and stomach ache reports that fall under the broader GI category
This most recent study provide some reassurance that at least, in the short term (1-3 years), we can say that GLP1-RA is not associated with the risk of thyroid cancers